ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer	Metastatic Castration-resistant Prostate Cancer (mCRPC); Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	Recruiting	Phase 3	2025-04-09		NCT03903835

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
Cancerfonden	2
Janssen Pharmaceutica N.V., Belgium	13
Karolinska Institutet	493
Kom Op Tegen Kanker	20
The Swedish Research Council	57

32 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Akademiska sjukhuset	Uppsala	Sweden	11
Akershus Universitetssykehus	Lørenskog	Norway	2
AZ Damiaan	Ostend	Belgium	2
AZ Groeninge	Kortrijk	Belgium	18
AZ Jan Palfijn Ziekenhuis	Ghent	Belgium	1
AZ Sint-Jan AV	Bruges	Belgium	1
AZ Sint-Lucas	Bruges	Belgium	2
Capio St.Görans Hospital	Stockholm	Sweden	1
Centrallasarettet Onkologkliniken	Vaxjo	Sweden	1
Centralsjukhuset Region Värmland	Karlstad	Sweden	1
Falu lasarett	Falun	Sweden	1
GZA Sint-Augustinus	Antwerp	Belgium	1
Hallands sjukhus Varberg	Varberg	Sweden	2
Jessa Ziekenhuis	Hasselt	Belgium	18
Karolinska University Hospital	Stockholm	Sweden	35
Kreftsenter Kristiansand	Kristiansand	Norway	1
Länssjukhuset	Kalmar	Sweden	1
Länssjukhuset Ryhov - Onkologiska kliniken	Jönköping	Sweden	1
Länssjukhuset Sundsvall Härnösand	Sundsvall	Sweden	1
Norrlands Universitetssjukhus	Umeå	Sweden	4
OLV Ziekenhuis Aalst	Aalst	Belgium	2
St. Claraspital	Basel	Switzerland	3
Stavanger Universitetssjukehus	Stavanger	Norway	3
Södra Alvsborgs sjukhus	Borås	Sweden	1
Universitetssjukhuset Örebro	Örebro	Sweden	6

Clinical trials